使用dupilumab治疗免疫相关的皮肤不良事件的管理
Alyce Mei-Shiuan Kuo1, Stephanie Gu1, Joseph Stoll1,2
1Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Journal for immunotherapy of cancer
|June 3, 2023
概括
杜皮卢马布有效治疗接受免疫检查点抑制剂 (ICI) 的癌症患者的类固醇耐药性免疫相关皮肤不良事件 (irAEs). 这项研究表明dupilumab为这些具有挑战性的irAEs提供了良好的耐受性和高响应率.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 可以在70-90%的患者中引起与免疫相关的皮肤不良事件 (irAEs).
- 类固醇耐火或类固醇依赖的IRAE构成了严重的治疗挑战.
研究的目的:
- 评估dupilumab在治疗类固醇耐药或类固醇依赖的irAEs的疗效和安全性.
- 描述这个队列中患者的结果和组织病理学发现.
主要方法:
- 从2017年3月至2021年10月,对患者进行回顾性研究,这些患者在irAEs治疗中使用dupilumab.
- 评估了临床反应率,不良事件,实验室值,并审查了他的病理学.
主要成果:
- 87%的患者对dupilumab有反应,其中44.1%的患者实现了完全解脱.
- 杜皮卢马布耐受性很好,只有一个患者因不良事件而停止治疗.
- 观察到,乙氨基酸细胞数量和免疫球蛋白E水平显著下降.
结论:
- 杜皮卢马布是一种有前途的治疗类固醇耐火性/依赖性irrAEs,特别是湿疹性,斑点性或性类型.
- 在这个队列中观察到高反应率和良好的耐受性.
- 需要进一步的前性随机试验来确认疗效和长期安全性.
相关概念视频
Hypersensitivities
807
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
807
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Skin Diseases and Disorders
3.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.9K
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
204
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
204
Drugs Used in Lower Respiratory Disorders: Overview
506
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
506


